These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 3000583)
21. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247 [TBL] [Abstract][Full Text] [Related]
22. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535 [TBL] [Abstract][Full Text] [Related]
24. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2. Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541 [TBL] [Abstract][Full Text] [Related]
25. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75. Carvajal A; Espinoza N; Kato S; Pinto M; Sadarangani A; Monso C; Aranda E; Villalon M; Richer JK; Horwitz KB; Brosens JJ; Owen GI Breast Cancer Res Treat; 2005 Nov; 94(2):171-83. PubMed ID: 16175315 [TBL] [Abstract][Full Text] [Related]
26. Presence of transforming growth factors in human breast cancer cells. Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663 [TBL] [Abstract][Full Text] [Related]
27. Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells. Murphy LJ; Sutherland RL; Lazarus L Biochem Biophys Res Commun; 1985 Sep; 131(2):767-73. PubMed ID: 2996526 [TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein. Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268 [TBL] [Abstract][Full Text] [Related]
29. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens. Murphy LC; Dotzlaw H Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382 [TBL] [Abstract][Full Text] [Related]
30. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741 [TBL] [Abstract][Full Text] [Related]
31. Effects of retinoic acid on the binding and mitogenic activity of epidermal growth factor. Jetten AM J Cell Physiol; 1982 Mar; 110(3):235-40. PubMed ID: 6282898 [TBL] [Abstract][Full Text] [Related]
32. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Benz C; Hollander C; Miller B Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973 [TBL] [Abstract][Full Text] [Related]
33. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells. Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729 [TBL] [Abstract][Full Text] [Related]
34. Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor. Dong XF; Berthois Y; Martin PM Anticancer Res; 1991; 11(2):737-43. PubMed ID: 2064328 [TBL] [Abstract][Full Text] [Related]
35. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Papa V; Reese CC; Brunetti A; Vigneri R; Siiteri PK; Goldfine ID Cancer Res; 1990 Dec; 50(24):7858-62. PubMed ID: 2253226 [TBL] [Abstract][Full Text] [Related]
36. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells. Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873 [TBL] [Abstract][Full Text] [Related]
37. Effect of testosterone on the growth properties and on epidermal growth factor receptor expression in the teratoma-derived tumorigenic cell line 1246-3A. Serrero G; Lepak NM; Hayashi J; Eisinger DP Cancer Res; 1992 Aug; 52(15):4242-7. PubMed ID: 1638538 [TBL] [Abstract][Full Text] [Related]
38. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000 [TBL] [Abstract][Full Text] [Related]
39. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. Kosano H; Takatani O Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419 [TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Fabbro D; Küng W; Roos W; Regazzi R; Eppenberger U Cancer Res; 1986 Jun; 46(6):2720-5. PubMed ID: 3008998 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]